Administration of pegfilgrastim (Neulasta; Amgen Inc.) on the same day as chemotherapy
Record ID 32013000573
English
Authors' recommendations:
Fever with accompanying low blood neutrophil count (febrile neutropenia [FN]) leads to morbidity and mortality in up to 10% of patients receiving chemotherapy. Granulocyte colony-stimulating factors (GCSFs) are used during or after chemotherapy to prevent FN. These recombinant cytokine proteins stimulate bone marrow proliferation, reduce the maturation time of neutrophils, increase peripheral neutrophil count, and prevent infection.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=15309
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Neoplasms
- Neutropenia
- Granulocyte Colony-Stimulating Factor
- Recombinant Proteins
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.